|
EP300-AS1 expression profile based on
|
*
Please note that low number(<10) of normal samples considered.
CHOL : Cholangiocarcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.917291E-02 |
|
*
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.878200E-03 |
| Normal-vs-Stage2 |
2.551001E-01 |
| Normal-vs-Stage3 |
NA |
| Normal-vs-Stage4 |
9.250432E-01 |
| Stage1-vs-Stage2 |
1.522119E-01 |
| Stage1-vs-Stage3 |
NA |
| Stage1-vs-Stage4 |
2.254950E-01 |
| Stage2-vs-Stage3 |
NA |
| Stage2-vs-Stage4 |
6.126966E-01 |
| Stage3-vs-Stage4 |
NA |
|
|
*
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.759476E-02 |
| Normal-vs-AfricanAmerican |
9.949734E-01 |
| Normal-vs-Asian |
7.977078E-02 |
| Caucasian-vs-AfricanAmerican |
6.302563E-01 |
| Caucasian-vs-Asian |
7.642114E-01 |
| AfricanAmerican-vs-Asian |
5.845814E-01 |
|
|
*
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.754429E-01 |
| Normal-vs-Female |
4.712608E-03 |
| Male-vs-Female |
9.706216E-02 |
|
|
*
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.122715E-03 |
| Normal-vs-Age(41-60Yrs) |
3.522604E-02 |
| Normal-vs-Age(61-80Yrs) |
5.626576E-02 |
| Normal-vs-Age(81-100Yrs) |
1.176643E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.369739E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.234749E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.298827E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.581078E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.63593424480515E-05 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.54411658778108E-07 |
|
|
*
Please note that low number(<10) of normal samples considered.
| Descriptions |
| NormalWeight | BMI is >=18.5 and <25 |
ExtremeWeight | BMI is >=25 and <30 |
| Obese | BMI is >=30 and <40 |
ExtremeObese | BMI is >=40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-NormalWeight |
2.142940E-02 |
| Normal-vs-ExtremeWeight |
2.959218E-01 |
| Normal-vs-Obese |
2.144263E-01 |
| Normal-vs-ExtremeObese |
NA |
| NormalWeight-vs-ExtremeWeight |
3.062223E-01 |
| NormalWeight-vs-Obese |
4.616683E-01 |
| NormalWeight-vs-ExtremeObese |
NA |
| ExtremeWeight-vs-Obese |
8.189499E-01 |
| ExtremeWeight-vs-ExtremeObese |
NA |
| Obese-vs-ExtremeObese |
NA |
|
|
*
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade1 |
NA |
| Normal-vs-Grade2 |
4.600012E-02 |
| Normal-vs-Grade3 |
6.562455E-02 |
| Normal-vs-Grade4 |
6.095001E-01 |
| Grade1-vs-Grade2 |
NA |
| Grade1-vs-Grade3 |
NA |
| Grade1-vs-Grade4 |
NA |
| Grade2-vs-Grade3 |
9.934985E-01 |
| Grade2-vs-Grade4 |
3.073939E-01 |
| Grade3-vs-Grade4 |
2.990157E-01 |
|
|
